サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1706774

脂漏性角化症治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2025-2035年

Seborrheic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 202 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
脂漏性角化症治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2025-2035年
出版日: 2025年02月26日
発行: Transparency Market Research
ページ情報: 英文 202 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脂漏性角化症治療市場- 調査範囲

TMRの調査レポート「世界の脂漏性角化症治療市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の脂漏性角化症治療市場の収益と予測を提供します。また、2025年から2035年までの世界の脂漏性角化症治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、脂漏性角化症治療市場を推察しました。

市場スナップショット
2024年の市場規模 25億米ドル
2035年の市場規模 45億米ドル
CAGR 5.8%

当レポートでは、世界の脂漏性角化症治療市場の競合情勢について調査しています。世界の脂漏性角化症治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の脂漏性角化症治療市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の脂漏性角化症治療市場の市場分析と予測, 2020-2035年

第5章 主要洞察

  • 主要な業界イベント（パートナーシップ、コラボレーション、合併、買収など）
  • 脂漏性角化症の概要
  • 治療アルゴリズム
  • 病気の診断
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 主要国・地域別の規制シナリオ
  • バリューチェーン分析
  • 価格動向
  • 主要競合が提供する製品のベンチマーク
  • 新規市場参入者のための市場開拓戦略

第6章 世界の市場分析と予測：治療の種類別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測治療の種類別, 2020-2035年
    • 薬理学的
      • 40％過酸化水素
      • タザロテンクリーム0.1％
      • アルファヒドロキシ酸（AHA）
      • ビタミンD3クリーム
    • 非薬理学的
      • 凍結療法
      • 電気乾燥術/掻爬術
      • 皮膚剥離
      • レーザー療法
      • その他（局所ケミカルピーリング、シェービング切除など）
  • 治療の種類別の市場の魅力

第7章 世界の市場分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：適応症別, 2020-2035年
    • 網状脂漏性角化症
    • メラノアカントーマ
    • クローン性脂漏性角化症
    • 炎症性脂漏性角化症
    • その他
  • 適応症別の市場の魅力

第8章 世界の市場分析と予測：治療の可用性別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測治療の可用性別, 2020-2035年
    • 薬理学的
      • 病院薬局
      • 小売薬局
      • オンライン薬局
    • 非薬理学的
      • 病院
      • 皮膚科クリニック
      • その他（手術センターなど）
  • 治療の可用性別による市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析企業別（2024年）
  • 企業プロファイル
    • Aclaris Therapeutics, Inc.
    • Quanta System, S.p.A.
    • BioLight Technologies LLC.
    • AngioDynamics
    • Alma Lasers
    • Becton Dickinson and Company
    • Erchonia Corporation
    • IRIDEX Corp
    • Cutera
    • Biolase Inc
    • Cosette Pharmaceuticals
    • Lumenis
    • Mayne Pharma Group Limited
    • Fermenta Biotech
    • Brenntag Nordic A/S
    • Other Prominent Players
図表

List of Tables

  • Table 01: Global Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Type, 2020-2035
  • Table 02: Global Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 03: Global Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035
  • Table 04: Global Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 05: North America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 06: North America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020-2035
  • Table 07: North America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 08: North America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035
  • Table 09: Europe - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 10: Europe - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020-2035
  • Table 11: Europe - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 12: Europe - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035
  • Table 13: Asia Pacific - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 14: Asia Pacific - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020-2035
  • Table 15: Asia Pacific - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 16: Asia Pacific - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035
  • Table 17: Latin America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 18: Latin America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020-2035
  • Table 19: Latin America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 20: Latin America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035
  • Table 21: Middle East & Africa - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 22: Middle East & Africa - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020-2035
  • Table 23: Middle East & Africa - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Indication, 2020-2035
  • Table 24: Middle East & Africa - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, By Treatment Availability, 2020-2035

List of Figures

  • Figure 01: Global Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, by Region, 2020-2035
  • Figure 02: Global Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 03: Global Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 04: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Pharmacological, 2020-2035
  • Figure 05: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Non-Pharmacological, 2020-2035
  • Figure 06: Global Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 07: Global Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 08: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Reticulated Seborrheic Keratosis, 2020-2035
  • Figure 09: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Melanoacanthoma, 2020-2035
  • Figure 10: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Clonal Seborrheic Keratosis, 2020-2035
  • Figure 11: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Irritated Seborrheic Keratosis, 2020-2035
  • Figure 12: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 13: Global Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 14: Global Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
  • Figure 15: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Pharmacological, 2020-2035
  • Figure 16: Global Seborrheic Keratosis Treatment Market Revenue (US$ Mn), by Non-Pharmacological, 2020-2035
  • Figure 17: Global Seborrheic Keratosis Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 18: Global Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 19: North America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 20: North America - Seborrheic Keratosis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 21: North America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 22: North America Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 23: North America Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 24: North America - Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 25: North America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 26: North America - Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 27: North America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
  • Figure 28: Europe - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 29: Europe - Seborrheic Keratosis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: Europe - Seborrheic Keratosis Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 31: Europe Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 32: Europe Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 33: Europe - Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 34: Europe - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 35: Europe - Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 36: Europe - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
  • Figure 37: Asia Pacific - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 38: Asia Pacific - Seborrheic Keratosis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 39: Asia Pacific - Seborrheic Keratosis Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 40: Asia Pacific Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 41: Asia Pacific Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 42: Asia Pacific - Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 43: Asia Pacific - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 44: Asia Pacific - Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 45: Asia Pacific - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
  • Figure 46: Latin America - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 47: Latin America - Seborrheic Keratosis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 48: Latin America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 49: Latin America Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 50: Latin America Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 51: Latin America - Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 52: Latin America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 53: Latin America - Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 54: Latin America - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
  • Figure 55: Middle East & Africa - Seborrheic Keratosis Treatment Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 56: Middle East & Africa - Seborrheic Keratosis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 57: Middle East & Africa - Seborrheic Keratosis Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 58: Middle East & Africa Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
  • Figure 59: Middle East & Africa Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Type, 2025-2035
  • Figure 60: Middle East & Africa - Seborrheic Keratosis Treatment Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 61: Middle East & Africa - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Indication, 2025-2035
  • Figure 62: Middle East & Africa - Seborrheic Keratosis Treatment Market Value Share Analysis, By Treatment Availability, 2024 and 2035
  • Figure 63: Middle East & Africa - Seborrheic Keratosis Treatment Market Attractiveness Analysis, By Treatment Availability, 2025-2035
目次
Product Code: TMRGL86482

Seborrheic Keratosis Treatment Market - Scope of Report

TMR's report on the global seborrheic keratosis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global seborrheic keratosis treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global seborrheic keratosis treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the seborrheic keratosis treatment market.

Market Snapshot
Market Value in 2024US$ 2.5 Bn
Market Value in 2035US$ 4.5 Bn
CAGR5.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global seborrheic keratosis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global seborrheic keratosis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global seborrheic keratosis treatment market.

The report delves into the competitive landscape of the global seborrheic keratosis treatment market. Key players operating in the global seborrheic keratosis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global seborrheic keratosis treatment market profiled in this report.

Key Questions Answered in Global seborrheic keratosis treatment Market Report:

  • What is the sales/revenue generated by seborrheic keratosis treatment across all regions during the forecast period?
  • What are the opportunities in the global seborrheic keratosis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Seborrheic Keratosis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global seborrheic keratosis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global seborrheic keratosis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global seborrheic keratosis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Seborrheic Keratosis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events (Partnerships, Collaborations, Mergers, Acquisitions, etc.)
  • 5.2. Overview on Seborrheic Keratosis
  • 5.3. Treatment Algorithm
  • 5.4. Disease Diagnosis
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. PESTLE Analysis
  • 5.7. Regulatory Scenario by Key Countries/Regions
  • 5.8. Value Chain Analysis
  • 5.9. Pricing Trends
  • 5.10. Benchmarking of the Products Offered by the Leading Competitors
  • 5.11. Go-to-Market Strategy for New Market Entrants

6. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Treatment Type, 2020-2035
    • 6.3.1. Pharmacological
      • 6.3.1.1. 40% Hydrogen Peroxide
      • 6.3.1.2. Tazarotene cream 0.1%
      • 6.3.1.3. Alpha Hydroxy Acid (AHA)
      • 6.3.1.4. Vitamin D3 cream
    • 6.3.2. Non-Pharmacological
      • 6.3.2.1. Cryotherapy
      • 6.3.2.2. Electrodessication/Curettage
      • 6.3.2.3. Dermabrasion
      • 6.3.2.4. Laser Therapy
      • 6.3.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 6.4. Market Attractiveness By Treatment Type

7. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Indication, 2020-2035
    • 7.3.1. Reticulated Seborrheic Keratosis
    • 7.3.2. Melanoacanthoma
    • 7.3.3. Clonal Seborrheic Keratosis
    • 7.3.4. Irritated Seborrheic Keratosis
    • 7.3.5. Others
  • 7.4. Market Attractiveness By Indication

8. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Treatment Availability

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Treatment Availability, 2020-2035
    • 8.3.1. Pharmacological
      • 8.3.1.1. Hospital Pharmacy
      • 8.3.1.2. Retail Pharmacy
      • 8.3.1.3. Online Pharmacy
    • 8.3.2. Non-Pharmacological
      • 8.3.2.1. Hospitals
      • 8.3.2.2. Dermatology Clinics
      • 8.3.2.3. Others (Surgery Centers, etc.)
  • 8.4. Market Attractiveness By Treatment Availability

9. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Seborrheic Keratosis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Treatment Type, 2020-2035
    • 10.2.1. Pharmacological
      • 10.2.1.1. 40% Hydrogen Peroxide
      • 10.2.1.2. Tazarotene cream 0.1%
      • 10.2.1.3. Alpha Hydroxy Acid (AHA)
      • 10.2.1.4. Vitamin D3 cream
    • 10.2.2. Non-Pharmacological
      • 10.2.2.1. Cryotherapy
      • 10.2.2.2. Electrodessication/Curettage
      • 10.2.2.3. Dermabrasion
      • 10.2.2.4. Laser Therapy
      • 10.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 10.3. Market Value Forecast By Indication, 2020-2035
    • 10.3.1. Reticulated Seborrheic Keratosis
    • 10.3.2. Melanoacanthoma
    • 10.3.3. Clonal Seborrheic Keratosis
    • 10.3.4. Irritated Seborrheic Keratosis
    • 10.3.5. Others
  • 10.4. Market Value Forecast By Treatment Availability, 2020-2035
    • 10.4.1. Pharmacological
      • 10.4.1.1. Hospital Pharmacy
      • 10.4.1.2. Retail Pharmacy
      • 10.4.1.3. Online Pharmacy
    • 10.4.2. Non-Pharmacological
      • 10.4.2.1. Hospitals
      • 10.4.2.2. Dermatology Clinics
      • 10.4.2.3. Others (Surgery Centers, etc.)
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Treatment Type
    • 10.6.2. By Indication
    • 10.6.3. By Treatment Availability
    • 10.6.4. By Country

11. Europe Seborrheic Keratosis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Treatment Type, 2020-2035
    • 11.2.1. Pharmacological
      • 11.2.1.1. 40% Hydrogen Peroxide
      • 11.2.1.2. Tazarotene cream 0.1%
      • 11.2.1.3. Alpha Hydroxy Acid (AHA)
      • 11.2.1.4. Vitamin D3 cream
    • 11.2.2. Non-Pharmacological
      • 11.2.2.1. Cryotherapy
      • 11.2.2.2. Electrodessication/Curettage
      • 11.2.2.3. Dermabrasion
      • 11.2.2.4. Laser Therapy
      • 11.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 11.3. Market Value Forecast By Indication, 2020-2035
    • 11.3.1. Reticulated Seborrheic Keratosis
    • 11.3.2. Melanoacanthoma
    • 11.3.3. Clonal Seborrheic Keratosis
    • 11.3.4. Irritated Seborrheic Keratosis
    • 11.3.5. Others
  • 11.4. Market Value Forecast By Treatment Availability, 2020-2035
    • 11.4.1. Pharmacological
      • 11.4.1.1. Hospital Pharmacy
      • 11.4.1.2. Retail Pharmacy
      • 11.4.1.3. Online Pharmacy
    • 11.4.2. Non-Pharmacological
      • 11.4.2.1. Hospitals
      • 11.4.2.2. Dermatology Clinics
      • 11.4.2.3. Others (Surgery Centers, etc.)
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Treatment Type
    • 11.6.2. By Indication
    • 11.6.3. By Treatment Availability
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Seborrheic Keratosis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Treatment Type, 2020-2035
    • 12.2.1. Pharmacological
      • 12.2.1.1. 40% Hydrogen Peroxide
      • 12.2.1.2. Tazarotene cream 0.1%
      • 12.2.1.3. Alpha Hydroxy Acid (AHA)
      • 12.2.1.4. Vitamin D3 cream
    • 12.2.2. Non-Pharmacological
      • 12.2.2.1. Cryotherapy
      • 12.2.2.2. Electrodessication/Curettage
      • 12.2.2.3. Dermabrasion
      • 12.2.2.4. Laser Therapy
      • 12.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 12.3. Market Value Forecast By Indication, 2020-2035
    • 12.3.1. Reticulated Seborrheic Keratosis
    • 12.3.2. Melanoacanthoma
    • 12.3.3. Clonal Seborrheic Keratosis
    • 12.3.4. Irritated Seborrheic Keratosis
    • 12.3.5. Others
  • 12.4. Market Value Forecast By Treatment Availability, 2020-2035
    • 12.4.1. Pharmacological
      • 12.4.1.1. Hospital Pharmacy
      • 12.4.1.2. Retail Pharmacy
      • 12.4.1.3. Online Pharmacy
    • 12.4.2. Non-Pharmacological
      • 12.4.2.1. Hospitals
      • 12.4.2.2. Dermatology Clinics
      • 12.4.2.3. Others (Surgery Centers, etc.)
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Treatment Type
    • 12.6.2. By Indication
    • 12.6.3. By Treatment Availability
    • 12.6.4. By Country/Sub-region

13. Latin America Seborrheic Keratosis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Treatment Type, 2020-2035
    • 13.2.1. Pharmacological
      • 13.2.1.1. 40% Hydrogen Peroxide
      • 13.2.1.2. Tazarotene cream 0.1%
      • 13.2.1.3. Alpha Hydroxy Acid (AHA)
      • 13.2.1.4. Vitamin D3 cream
    • 13.2.2. Non-Pharmacological
      • 13.2.2.1. Cryotherapy
      • 13.2.2.2. Electrodessication/Curettage
      • 13.2.2.3. Dermabrasion
      • 13.2.2.4. Laser Therapy
      • 13.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 13.3. Market Value Forecast By Indication, 2020-2035
    • 13.3.1. Reticulated Seborrheic Keratosis
    • 13.3.2. Melanoacanthoma
    • 13.3.3. Clonal Seborrheic Keratosis
    • 13.3.4. Irritated Seborrheic Keratosis
    • 13.3.5. Others
  • 13.4. Market Value Forecast By Treatment Availability, 2020-2035
    • 13.4.1. Pharmacological
      • 13.4.1.1. Hospital Pharmacy
      • 13.4.1.2. Retail Pharmacy
      • 13.4.1.3. Online Pharmacy
    • 13.4.2. Non-Pharmacological
      • 13.4.2.1. Hospitals
      • 13.4.2.2. Dermatology Clinics
      • 13.4.2.3. Others (Surgery Centers, etc.)
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Treatment Type
    • 13.6.2. By Indication
    • 13.6.3. By Treatment Availability
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Seborrheic Keratosis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Treatment Type, 2020-2035
    • 14.2.1. Pharmacological
      • 14.2.1.1. 40% Hydrogen Peroxide
      • 14.2.1.2. Tazarotene cream 0.1%.
      • 14.2.1.3. Alpha Hydroxy Acid (AHA)
      • 14.2.1.4. Vitamin D3 cream
    • 14.2.2. Non-Pharmacological
      • 14.2.2.1. Cryotherapy
      • 14.2.2.2. Electrodessication/Curettage
      • 14.2.2.3. Dermabrasion
      • 14.2.2.4. Laser Therapy
      • 14.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
  • 14.3. Market Value Forecast By Indication, 2020-2035
    • 14.3.1. Reticulated Seborrheic Keratosis
    • 14.3.2. Melanoacanthoma
    • 14.3.3. Clonal Seborrheic Keratosis
    • 14.3.4. Irritated Seborrheic Keratosis
    • 14.3.5. Others
  • 14.4. Market Value Forecast By Treatment Availability, 2020-2035
    • 14.4.1. Pharmacological
      • 14.4.1.1. Hospital Pharmacy
      • 14.4.1.2. Retail Pharmacy
      • 14.4.1.3. Online Pharmacy
    • 14.4.2. Non-Pharmacological
      • 14.4.2.1. Hospitals
      • 14.4.2.2. Dermatology Clinics
      • 14.4.2.3. Others (Surgery Centers, etc.)
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Treatment Type
    • 14.6.2. By Indication
    • 14.6.3. By Treatment Availability
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Aclaris Therapeutics, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Quanta System, S.p.A.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. BioLight Technologies LLC.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. AngioDynamics
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Alma Lasers
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Becton Dickinson and Company
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Erchonia Corporation
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. IRIDEX Corp
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Cutera
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Biolase Inc
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Cosette Pharmaceuticals
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Lumenis
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Mayne Pharma Group Limited
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Fermenta Biotech
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Brenntag Nordic A/S
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Financial Overview
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments
    • 15.3.16. Other Prominent Players
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Financial Overview
      • 15.3.16.3. Financial Overview
      • 15.3.16.4. Business Strategies
      • 15.3.16.5. Recent Developments